SFS
PTLA

Sowell Financial Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Sowell Financial Services’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-60
Closed – – 2784
2020
Q1 		$0 Sell
60
-39
-39% -$487 ﹤0.01% 2818
2019
Q4 		$2K Sell
99
-39
-28% -$1.08K ﹤0.01% 2269
2019
Q3 		$4K Buy
+138
New +$3.87K ﹤0.01% 1894

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return

Sowell Financial Services's PTLA Position: Q2 2020 in Review

Sowell Financial Services sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 60 shares.

Sowell Financial Services first reported a position in PTLA in Q3 2019 and held it in 3 quarters. The position peaked at $4K in Q3 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • Sowell Financial Services reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Sowell Financial Services sold 60 Portola Pharmaceuticals, Inc. shares in Q2 2020.
  • Sowell Financial Services first reported a position in Portola Pharmaceuticals, Inc. in Q3 2019 and held it in 3 quarters.
  • Sowell Financial Services's Portola Pharmaceuticals, Inc. position peaked at $4K in Q3 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Sowell Financial Services's 13F filing for Q2 2020, filed 13 Aug 2020.